JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs 
NIO CEO Says China’s Auto Industry Has Passed Its Golden Era Amid Weak Car Sales 
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure 
US Quantum Stocks Surge After $2 Billion Government Investment 
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground 
Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge 
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding 
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026 
SQM Q1 Profit More Than Doubles as Lithium Prices Surge 
Samsung Union Dispute Escalates Over Semiconductor Bonus Vote 
Universal Music Group Rejects Pershing Square Takeover Proposal 
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences:
- Piper Jaffray 27th Annual Healthcare Conference in New York at 8:30 a.m. ET on Wednesday, December 2, 2015. The live and archived webcast will be available at http://edge.media-server.com/m/p/u46tsbd2.
- Oppenheimer 26th Annual Healthcare Conference in New York at 9:45 a.m. ET on December 9, 2015. The live and archived webcast will be available at http://www.veracast.com/webcasts/opco/healthcare2015/84203554236.cfm.
Geron management will also be hosting an analyst and investor meeting to discuss imetelstat data presented at the 57th American Society of Hematology (ASH) Annual Meeting:
- The meeting will be held at 7:30 p.m. ET on Saturday, December 5, 2015. The live and archived webcast will be available at http://edge.media-server.com/m/p/o3ovz2db/lan/en.
Following the live presentations, the webcasts will be archived and available for replay for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]
